Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
about
The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosisInterleukin-17 and acute coronary syndromeImmunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndromeB cell subsets in atherosclerosis.Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosisInterleukin 17 in vascular inflammation.Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice.Th 17 cells interplay with Foxp3+ Tregs in regulation of inflammation and autoimmunity.Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatmentEmerging role of IL-17 in atherosclerosis.Gamma delta T cells recognize haptens and mount a hapten-specific response.T cells in vascular inflammatory diseasesMechanisms of premature atherosclerosis in rheumatoid arthritis and lupusThe inhibitory FcγRIIb modulates the inflammatory response and influences atherosclerosis in male apoE(-/-) miceRole of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice.Lymphocytes in atherosclerosis.Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritisThe interplay of inflammation and cardiovascular disease in systemic lupus erythematosus.Reduced Atherosclerosis in apoE-inhibitory FcγRIIb-Deficient Mice Is Associated With Increased Anti-Inflammatory Responses by T Cells and MacrophagesAttenuated atherosclerotic lesions in apoE-Fcγ-chain-deficient hyperlipidemic mouse model is associated with inhibition of Th17 cells and promotion of regulatory T cells.CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in miceLymphocyte migration into atherosclerotic plaque.Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets.MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors.The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitmentMycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation.Plasmacytoid dendritic cells in atherosclerosis.Atherosclerosis and rheumatoid arthritis: more than a simple association.Adaptive immunity in atherogenesis: new insights and therapeutic approaches.Aortic VCAM-1: an early marker of vascular inflammation in collagen-induced arthritis.CXCR6 regulates the recruitment of pro-inflammatory IL-17A-producing T cells into atherosclerotic aortasThe role of the vascular dendritic cell network in atherosclerosis.Stat3β mitigates development of atherosclerosis in apolipoprotein E-deficient miceInterleukin-27 receptor limits atherosclerosis in Ldlr-/- mice.T helper cell polarization in healthy people: implications for cardiovascular diseaseInterleukin-6-signal transducer and activator of transcription-3 signaling mediates aortic dissections induced by angiotensin II via the T-helper lymphocyte 17-interleukin 17 axis in C57BL/6 miceIncreased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A.Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis.Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus.IL-17A is proatherogenic in high-fat diet-induced and Chlamydia pneumoniae infection-accelerated atherosclerosis in mice.
P2860
Q26996707-B968C01A-71FF-4180-B6C6-0AE1E66647BEQ27025823-0A25A9D0-2929-4A63-9879-E6BBFACD46B3Q28071723-56DDAD39-B772-4922-8E1B-F236830CC2CFQ30423324-CF997C49-176A-405B-8E1D-52B44DB27F6DQ30425368-36A0BF03-9B85-4608-94C2-73486AE094EAQ30429445-43184ABB-51B6-4E6F-9207-DF6E22ADC8D4Q30432644-1AE6AD69-E444-4828-A011-5572BCD0ED5AQ33894387-FECC540D-414E-4B89-BC87-DC41A6B0AFDEQ33943374-59419929-CB66-4E75-AD3D-E42BB496DA9FQ33955912-4C5CD87A-096B-49E4-93C4-5B2A6A6F2679Q34241427-BF8BCDFB-9F94-418B-9C5E-985FF8A8748DQ34336323-B66402DC-C43E-47CD-8674-1980777C0C5AQ34343906-FF81A055-9329-4328-86A1-6BB620E384EBQ34644753-D27FB800-CE0C-4BF1-8FE2-438112E31C55Q35050827-EA62147C-AF19-4A02-B4D0-57A6B353BB57Q35082438-9230CD84-7EFD-4F96-9C8F-BCC1EF9AC96DQ35152141-402353F4-318B-4FE3-8836-2F2E5F3A06F4Q35169351-504EB7AD-423D-4129-9261-C6B936E0A959Q35537314-9F11F68F-162F-4368-A475-191763AB012CQ35566640-CDE6056D-7AD0-4699-819C-18AD3A14F517Q35572404-21B3E2C2-8FB7-4123-A5EF-5135566A5EF0Q35600904-3238B7DB-5872-4F67-A7A9-67C17D3F54A2Q35640438-A134EF37-ECBC-4F57-8BB8-EC0D5EDD5BDBQ35786288-C6BD518D-4E9D-4A54-A0A3-FCD8DEEEF206Q35915712-B2FC21B1-ADCD-4747-B488-34A57E6A1EA1Q36043804-E9148D51-BBA7-4385-AD49-49F7BA77380AQ36064574-81198ABE-144D-467A-9CD5-528F74717FCBQ36253671-4930BBD5-D6CF-4B0F-B34C-B041D93C0DE0Q36497196-4F75BE0C-7E37-4644-AE16-B26096E1C80DQ36797524-DE3FBF4D-22A3-4DED-95F7-F52B97271678Q36954815-EB9BBA58-4A28-4952-915C-DE8D681702BFQ37050929-21F75E6D-4BC1-4193-9DC2-28085D6107FFQ37084572-73E29B14-9309-4BA5-9D20-B0CB09A64242Q37114519-AA8634A2-8829-43E0-9AFA-A151D7300364Q37250335-84A3F2DC-36F6-4AD4-BA43-4B51D71E2096Q37281580-6C637ABA-55CA-4734-BB24-F3A19AEABC06Q37358482-C8AB05D4-B0F5-4768-BCA7-31BC7571F7C1Q37407750-D51233F0-AF74-4459-BB59-0FA39CE7403FQ37699812-070446FB-67A3-4458-B7DB-EC2D666A4B7CQ37852203-F46FB738-B106-49B5-A9A1-E5C75A1ED959
P2860
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
@en
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
@nl
type
label
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
@en
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
@nl
prefLabel
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
@en
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
@nl
P2093
P1476
Attenuated atherosclerosis upon IL-17R signaling disruption in LDLr deficient mice.
@en
P2093
F M E Segers
G H M van Puijvelde
I M Michon
L A Joosten
Th J C van Berkel
W B van den Berg
P304
P356
10.1016/J.BBRC.2009.07.152
P407
P577
2009-08-04T00:00:00Z